Crossmark

C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation

Crossref DOI link: https://doi.org/10.1007/s12032-023-02296-z

Published Online: 2024-01-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al Shahrani, Mesfer

Gahtani, Reem M.

Makkawi, Mohammed https://orcid.org/0000-0003-3901-7267
Funding

Funding for this research was provided by:

Deanship of Scientific Research, King Khalid University (R.G.P.1/283/44)
License Information

Text and Data Mining valid from 2024-01-24

Version of Record valid from 2024-01-24
More Information

Article History

Received: 9 November 2023

Accepted: 28 December 2023

First Online: 24 January 2024

Declarations

:

: All authors of this manuscript declare that there is no conflict of interest related to the study.

Document is current

Any future updates will be listed below